A Phase 1 Study of Oral LY3410738 in Patients with Advanced Hematologic Malignancies with IDH1 or IDH2 Mutations.

Principal investigator: Kimmo Porkka
HUS Helsinki University Hospital, Comprehensive Cancer Center

Link to the ClinicalTrials.gov study website